59MDWI44-103 — Quality Assessment For Point Of Care Testing

59MDWI44-103 governs quality assessment for Point of Care Testing and establishes policies and procedures for POCT.

Search 59MDWI44-103

  • Publication number: 59MDWI44-103
  • Title: QUALITY ASSESSMENT FOR POINT OF CARE TESTING
  • Date: 2019-05-09

View 59MDWI44-103 on armypubs.army.mil

It addresses personnel requirements, patient results, new testing sites, privileged provider testing, and patient safety. It requires training, documentation, quality controls, licensing, result confirmation, and patient identification.

Applies to: This instruction applies to any clinical service, or outpatient, involved with procedures pertinent to the Point of Care Testing (POCT) program.

Topics covered

  • Point of Care Testing personnel
  • POCT patient results
  • New POCT site proposals
  • Privileged provider performed testing
  • Patient identification
  • Telephone order read-back
  • Laboratory alarm systems

Questions and answers

How must personnel document reagents and strips used for POCT?

On all reagents and strips, the date “in-use”, the expiration date, and the user’s initials must be listed. (paragraph 1)

When are additional confirmatory tests required for POCT results?

When results are inconsistent with these expectations, additional confirmatory tests must be performed. (paragraph 3)

Can the whole blood glucose procedure definitively diagnose diabetes?

The whole blood glucose procedure may be used to diagnose hypoglycemia and to guide therapy in emergent and urgent situations, but the procedure may not be used to definitively diagnose diabetes. (paragraph 3)

What is required before a new Point of Care Testing site can be established?

Committee approval is required before a Point of Care Testing site can be established. (paragraph 4)

What licensing requirement applies to privileged provider testing?

Any clinic or ward within 59 MDW that provides testing, personally performed by a privileged provider must be registered with the Center for Clinical Laboratory Management to obtain required licensing. (paragraph 5)

Ask Reggie.Bot a question about 59MDWI44-103